The global infusion therapy market 2020 is predicted to have a positive impact due to the pandemic caused by COVID 19. The pandemic has affected all other markets, including the infusion therapy market, but some dominant factors have sustained the market’s growth optimistically. This could be explained appropriately in the Market Research Future’s latest report that came up with a thorough study keeping the impact of COVID 19. Thus, the report stated that 4.9% is recorded for the growth, which would take place during the period—2017 to 2025. During these years, substantial revenue is promised to be achieved.
Request Sample Copy:
Infusion therapy Boomers & Decliners
The infusion systems market is anticipated to expand in the assessment period owing to driving factors such as the escalating prevalence of chronic diseases such as strokes, cardiovascular disease, type 2 diabetes, cancer, and more. In fact, rising technological advancements, geriatric population, rising healthcare expenditure, and its portability and easy to use the feature and visual monitoring features are also helping the market to grow.
In the last few decades, the clinical and surgical industry, volumetric and syringe pumps, infusion systems have been extensively used for intravenous therapy (IV). Industry experts predict that 80% of hospitalized patients receive intravenous (IV) therapy. Such a demand might boost in the coming years. In fact, the mounting incidence of chronic lifestyle disorders such as cancer, diabetes, and the surged rate of an aging population are the foremost factors that are expected to raise the demand for the infusion systems market in the forecast period.
With the boost in the number of infections worldwide, hospitals are facing a shortage of infusion pumps and systems to treat COVID-19 patients using nebulization support.
Infusion System market is studied among the segments of product type, which comprises of IV disposable, infusion pump, and more. IV disposable grabbed the prevalent market share of the total market in 2016.
Depending on the segment of the application, the market has included diabetes, Chemotherapy, pediatrics, gastrointestinal diseases, and others. The chemotherapy segment grabbed the prevalent market share of the total market in the year 2016.
Depending on the segment of end-user, the market has included homecare, specialty oncology wards, hospitals, and others. Hospitals led the global market with the largest market share in the year 2018.
Region-wise, the infusion system market is studied among regions such as North America, Europe, Europe, Asia-Pacific, Middle East, and Africa.
North America grabs the prevalent market share globally. The infusion system market in Asia-Pacific and Latin America might expand relatively fast in the coming years. Factors expected to drive this growth are a boost in population and an increase in incidences of cancer, diabetes, and asthma.
The key vendors of the global infusion systems market are listed as B. BRAUN MELSUNGEN AG, 3M, Becton, Baxter, Fresenius Kabi AG, Dickinson, and Company, Inc, Smiths Medical, ICU Medical, and Terumo Medical Corporation.
Browse Full Report@
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
+1 646 845 9312